当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第23期
编号:13282793
TGF—β信号通路促进小鼠乳腺癌活检相关性肺转移的实验研究(5)
http://www.100md.com 2018年8月15日 《中国现代医生》 2018年第23期
     [17]Hasegawa S,Nagano H,Konno M,et al.A crucial epithelial to mesenchymal transition regulator,Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients[J]. Int J Oncol,2016,48(1):145-152.

    [18]Zhang J,Liang Q,Lei Y,et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression[J].Cancer Res,2012,72(17):4597-4608.

    [19]Chen L,Xiao Z,Meng Y,et al.The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs[J].Biomaterials,2012,33(5):1437-1444.

    [20]Luo H,Jiang Y,Ma S,et al. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3[J]. Biochem Biophys Res Commun,2016,479(2):253-259.

    [21]Luan QX,Zhang BG,Li XJ,et al. MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance[J].Eur Rev Med Pharmacol Sci,2016,20(20):4257-4265.

    [22]甘藝,吴正升,吴强.乳腺癌组织中SOX4、EZH2的表达及临床意义[J].临床与实验病理学杂志,2017,33(5):477-481.

    [23]Jang SH,Lee JE,Oh MH et al.High EZH2 protein expression is associated with poor overall survival in patients with luminal a breast cancer[J].J Breast Cancer,2016,19(1):53-60.

    (收稿日期:2018-02-07), 百拇医药(傅永强 郭方明 陈浩浩)
上一页1 2 3 4 5